Gene · 8835
Papers2,451
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,451
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The E3 ubiquitin ligase mechanism specifying target-directed microRNA degradation. | bioRxiv | 2026 | 41542392 | PubTator, text mining | PubMed |
| Butyrate ameliorates lung inflammation in chronic obstructive pulmonary disease in association with the regulation of histone lactylation: A mechanistic study. | Life Sci | 2026 | 41443468 | PubTator, text mining | PubMed |
| UBE2T promotes papillary thyroid carcinoma progression by activating the JAK/STAT3 pathway via negative regulation of SOCS2. | Semin Oncol | 2026 | 41330207 | PubTator, text mining | PubMed |
| Suppressor of cytokine signaling 2 is associated with growth impairment in pediatric chronic kidney disease. | Pediatr Nephrol | 2026 | 41315103 | PubTator, text mining | PubMed |
| LncRNA PVT1 promotes proliferation, migration and invasion of cholangiocarcinoma by regulating the expression of SOCS2. | Sci Rep | 2025 | 41449252 | PubTator, text mining | PubMed |
| Explainable AI unravels sepsis heterogeneity via coagulation-inflammation profiles for prognosis and stratification. | Nat Commun | 2025 | 41285832 | PubTator, text mining | PubMed |
| Development of a diagnostic model for MASLD and identification of daidzein as the potential drug using bioinformatics analysis and experiments. | Front Immunol | 2025 | 41200186 | PubTator, text mining | PubMed |
| Downregulation of the Tumor Suppressor P53 Gene associated with the Progression of Clinical Staging and the Incidence of Distant Metastasis in Indonesian Colorectal Cancer. | Korean J Gastroenterol | 2025 | 41132024 | PubTator, text mining | PubMed |
| Small-molecule degron mimetics for targeted protein degradation. | Essays Biochem | 2025 | 41124365 | PubTator, text mining | PubMed |
| Uncovering biomarkers and molecular pathways linking NAFLD and AIS: Insights from bioinformatic analysis and experiment. | PLoS One | 2025 | 41021615 | PubTator, text mining | PubMed |
| Long non-coding RNA-based single and combination independent prognostic biomarkers for hepatocellular carcinoma. | Discov Oncol | 2025 | 40892177 | PubTator, text mining | PubMed |
| SOCS Proteins: Key Players in Immune Regulation During SARS-CoV-2 Infection. | Eur J Immunol | 2025 | 40844207 | PubTator, text mining | PubMed |
| Comprehensive evaluation of risk factors for LNM and distant metastasis in patients with NSCLC. | Sci Rep | 2025 | 40841419 | PubTator, text mining | PubMed |
| Emerging implications of N6-methyladenosine in prostate cancer progression and treatment. | Cell Death Discov | 2025 | 40830264 | PubTator, text mining | PubMed |
| Research progress of SOCS in autoimmune diseases: mechanisms and therapeutic implications. | Front Immunol | 2025 | 40755762 | PubTator, text mining | PubMed |
| Identification of biomarkers between coronary artery disease and non-alcoholic steatohepatitis: a combination of bioinformatics and machine learning. | Front Genet | 2025 | 40747105 | PubTator, text mining | PubMed |
| M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges. | Front Oncol | 2025 | 40740874 | PubTator, text mining | PubMed |
| Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions. | Front Med (Lausanne) | 2025 | 40735439 | PubTator, text mining | PubMed |
| Design of a simple solution-processed universal shell for synthesizing reverse type-I core-shell structures toward high-efficiency water-splitting photocathodes. | RSC Adv | 2025 | 40734934 | PubTator, text mining | PubMed |
| RNA m6A modification: a key regulator in normal and malignant processes. | Cell Investig | 2025 | 40734692 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8835/papers?page=3